主营介绍

  • 产品类型:

    医药

  • 产品名称:

    药品 设备及技术

  • 经营范围:

    中、西生化药品生产、销售。软件开发、信息技术咨询服务、自有房地产经营活动、其他专业技术服务业、技术推广服务。(依法须经批准的项目,经相关部门批准后方可开展经营活动。)

运营业务数据

最新公告日期:2018-04-28 
业务名称 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2014-06-30
药品销量(片) 1.96亿 2.81亿 - - -
诊断仪器销量(台) 853.00 676.00 - - -
电力销量(千瓦时) - 47.69亿 - - -
复方鳖甲软肝片销量(片) - - 2.64亿 - -
诊断设备销量(台) - - 558.00 - -
壳脂胶囊销售(粒) - - - 1474.10万 -
软肝片销售(片) - - - 2.45亿 -
壳脂胶囊发货量(粒) - - - - 673.00万
软肝片发货量(片) - - - - 1.07亿
Fibroscan产品销量(台) - - - - 257.00

主营构成分析

{"2017-12-31":{"YYSR":{"1":[["\u533b\u7597\u5668\u68b0\u4e1a","49353.47"],["\u836f\u54c1\u53ca\u751f\u7269\u5236\u54c1\u4e1a","35614.04"]],"2":[["\u8bbe\u5907\u53ca\u6280\u672f","49353.47"],["\u81ea\u6709\u836f\u54c1","23200.03"],["\u6d41\u901a\u836f\u54c1","7560.80"],["\u5176\u4ed6","4853.20"]],"3":[["\u56fd\u5916","49353.47"],["\u56fd\u5185","35614.04"]]},"YYCB":{"1":[["\u533b\u7597\u5668\u68b0\u4e1a",""],["\u836f\u54c1\u53ca\u751f\u7269\u5236\u54c1\u4e1a",""]],"2":[["\u8bbe\u5907\u53ca\u6280\u672f","6068.11"],["\u81ea\u6709\u836f\u54c1","8146.84"],["\u6d41\u901a\u836f\u54c1","5309.57"],["\u5176\u4ed6","2355.83"]],"3":[["\u56fd\u5916","6068.11"],["\u56fd\u5185","15812.24"]]},"LRBL":{"1":[["\u533b\u7597\u5668\u68b0\u4e1a",""],["\u836f\u54c1\u53ca\u751f\u7269\u5236\u54c1\u4e1a",""]],"2":[["\u8bbe\u5907\u53ca\u6280\u672f","68.61"],["\u81ea\u6709\u836f\u54c1","23.86"],["\u6d41\u901a\u836f\u54c1","3.57"],["\u5176\u4ed6","3.96"]],"3":[["\u56fd\u5916","68.61"],["\u56fd\u5185","31.39"]]}},"2017-06-30":{"YYSR":{"2":[["\u8bbe\u5907\u53ca\u6280\u672f","23587.48"],["\u836f\u54c1","14951.13"],["\u5176\u4ed6","2228.73"]],"3":[["\u6d77\u5916\u5730\u533a","23587.48"],["\u4e2d\u56fd\u5927\u9646","17179.86"]]},"YYCB":{"2":[["\u8bbe\u5907\u53ca\u6280\u672f","2557.02"],["\u836f\u54c1","6100.77"],["\u5176\u4ed6","1049.04"]],"3":[["\u6d77\u5916\u5730\u533a","2557.02"],["\u4e2d\u56fd\u5927\u9646","7149.81"]]},"LRBL":{"2":[["\u8bbe\u5907\u53ca\u6280\u672f","67.71"],["\u836f\u54c1","28.49"],["\u5176\u4ed6","3.80"]],"3":[["\u6d77\u5916\u5730\u533a","67.71"],["\u4e2d\u56fd\u5927\u9646","32.29"]]}},"2016-12-31":{"YYSR":{"1":[["\u533b\u7597\u884c\u4e1a","82698.72"]],"2":[["\u836f\u54c1","41434.74"],["\u8bbe\u5907\u53ca\u6280\u672f","36898.69"],["\u5176\u4ed6","4365.28"]],"3":[["\u4e2d\u56fd\u5927\u9646","48862.42"],["\u6d77\u5916","33836.30"]]},"YYCB":{"1":[["\u533b\u7597\u884c\u4e1a","23088.15"]],"2":[["\u836f\u54c1","14931.69"],["\u8bbe\u5907\u53ca\u6280\u672f","5401.21"],["\u5176\u4ed6","2755.25"]],"3":[["\u4e2d\u56fd\u5927\u9646","18135.20"],["\u6d77\u5916","4952.95"]]},"LRBL":{"1":[["\u533b\u7597\u884c\u4e1a","100.00"]],"2":[["\u836f\u54c1","44.46"],["\u8bbe\u5907\u53ca\u6280\u672f","52.84"],["\u5176\u4ed6","2.70"]],"3":[["\u4e2d\u56fd\u5927\u9646","51.55"],["\u6d77\u5916","48.45"]]}}}
{"YYSR":{"chartWrap1":[{"name":"\u533b\u7597\u5668\u68b0\u4e1a","timeData":["2017-12-31"],"lineData":[49353.47],"columnData":[58.09],"unit":["4.94\u4ebf"]},{"name":"\u836f\u54c1\u53ca\u751f\u7269\u5236\u54c1\u4e1a","timeData":["2017-12-31"],"lineData":[35614.04],"columnData":[41.91],"unit":["3.56\u4ebf"]},{"name":"\u533b\u7597\u884c\u4e1a","timeData":["2016-12-31"],"lineData":[82698.72],"columnData":[100],"unit":["8.27\u4ebf"]}],"chartWrap2":[{"name":"\u8bbe\u5907\u53ca\u6280\u672f","timeData":["2017-12-31","2017-06-30","2016-12-31"],"lineData":[49353.47,23587.48,36898.69],"columnData":[58.09,57.86,44.62],"unit":["4.94\u4ebf","2.36\u4ebf","3.69\u4ebf"]},{"name":"\u81ea\u6709\u836f\u54c1","timeData":["2017-12-31"],"lineData":[23200.03],"columnData":[27.3],"unit":["2.32\u4ebf"]},{"name":"\u6d41\u901a\u836f\u54c1","timeData":["2017-12-31"],"lineData":[7560.8],"columnData":[8.9],"unit":["7560.80\u4e07"]},{"name":"\u5176\u4ed6","timeData":["2017-12-31","2017-06-30","2016-12-31"],"lineData":[4853.2,2228.73,4365.28],"columnData":[5.71,5.47,5.28],"unit":["4853.20\u4e07","2228.73\u4e07","4365.28\u4e07"]},{"name":"\u836f\u54c1","timeData":["2017-06-30","2016-12-31"],"lineData":[14951.13,41434.74],"columnData":[36.67,50.1],"unit":["1.50\u4ebf","4.14\u4ebf"]}],"chartWrap3":[{"name":"\u56fd\u5916","timeData":["2017-12-31"],"lineData":[49353.47],"columnData":[58.09],"unit":["4.94\u4ebf"]},{"name":"\u56fd\u5185","timeData":["2017-12-31"],"lineData":[35614.04],"columnData":[41.91],"unit":["3.56\u4ebf"]},{"name":"\u6d77\u5916\u5730\u533a","timeData":["2017-06-30"],"lineData":[23587.48],"columnData":[57.86],"unit":["2.36\u4ebf"]},{"name":"\u4e2d\u56fd\u5927\u9646","timeData":["2017-06-30","2016-12-31"],"lineData":[17179.86,48862.42],"columnData":[42.14,59.08],"unit":["1.72\u4ebf","4.89\u4ebf"]},{"name":"\u6d77\u5916","timeData":["2016-12-31"],"lineData":[33836.3],"columnData":[40.92],"unit":["3.38\u4ebf"]}]},"YYCB":{"chartWrap1":[{"name":"\u533b\u7597\u5668\u68b0\u4e1a","timeData":["2017-12-31"],"lineData":[0],"columnData":[0],"unit":["0.00"]},{"name":"\u836f\u54c1\u53ca\u751f\u7269\u5236\u54c1\u4e1a","timeData":["2017-12-31"],"lineData":[0],"columnData":[0],"unit":["0.00"]},{"name":"\u533b\u7597\u884c\u4e1a","timeData":["2016-12-31"],"lineData":[23088.15],"columnData":[100],"unit":["2.31\u4ebf"]}],"chartWrap2":[{"name":"\u8bbe\u5907\u53ca\u6280\u672f","timeData":["2017-12-31","2017-06-30","2016-12-31"],"lineData":[6068.11,2557.02,5401.21],"columnData":[27.73,26.34,23.39],"unit":["6068.11\u4e07","2557.02\u4e07","5401.21\u4e07"]},{"name":"\u81ea\u6709\u836f\u54c1","timeData":["2017-12-31"],"lineData":[8146.84],"columnData":[37.23],"unit":["8146.84\u4e07"]},{"name":"\u6d41\u901a\u836f\u54c1","timeData":["2017-12-31"],"lineData":[5309.57],"columnData":[24.27],"unit":["5309.57\u4e07"]},{"name":"\u5176\u4ed6","timeData":["2017-12-31","2017-06-30","2016-12-31"],"lineData":[2355.83,1049.04,2755.25],"columnData":[10.77,10.81,11.93],"unit":["2355.83\u4e07","1049.04\u4e07","2755.25\u4e07"]},{"name":"\u836f\u54c1","timeData":["2017-06-30","2016-12-31"],"lineData":[6100.77,14931.69],"columnData":[62.85,64.67],"unit":["6100.77\u4e07","1.49\u4ebf"]}],"chartWrap3":[{"name":"\u56fd\u5916","timeData":["2017-12-31"],"lineData":[6068.11],"columnData":[27.73],"unit":["6068.11\u4e07"]},{"name":"\u56fd\u5185","timeData":["2017-12-31"],"lineData":[15812.24],"columnData":[72.27],"unit":["1.58\u4ebf"]},{"name":"\u6d77\u5916\u5730\u533a","timeData":["2017-06-30"],"lineData":[2557.02],"columnData":[26.34],"unit":["2557.02\u4e07"]},{"name":"\u4e2d\u56fd\u5927\u9646","timeData":["2017-06-30","2016-12-31"],"lineData":[7149.81,18135.2],"columnData":[73.66,78.55],"unit":["7149.81\u4e07","1.81\u4ebf"]},{"name":"\u6d77\u5916","timeData":["2016-12-31"],"lineData":[4952.95],"columnData":[21.45],"unit":["4952.95\u4e07"]}]},"LRBL":{"chartWrap1":[{"name":"\u533b\u7597\u5668\u68b0\u4e1a","timeData":["2017-12-31"],"lineData":[0],"columnData":[0],"unit":["0.00"]},{"name":"\u836f\u54c1\u53ca\u751f\u7269\u5236\u54c1\u4e1a","timeData":["2017-12-31"],"lineData":[0],"columnData":[0],"unit":["0.00"]},{"name":"\u533b\u7597\u884c\u4e1a","timeData":["2016-12-31"],"lineData":[100],"columnData":[100],"unit":["100.00\u4e07"]}],"chartWrap2":[{"name":"\u8bbe\u5907\u53ca\u6280\u672f","timeData":["2017-12-31","2017-06-30","2016-12-31"],"lineData":[68.61,67.71,52.84],"columnData":[68.61,67.71,52.84],"unit":["68.61\u4e07","67.71\u4e07","52.84\u4e07"]},{"name":"\u81ea\u6709\u836f\u54c1","timeData":["2017-12-31"],"lineData":[23.86],"columnData":[23.86],"unit":["23.86\u4e07"]},{"name":"\u6d41\u901a\u836f\u54c1","timeData":["2017-12-31"],"lineData":[3.57],"columnData":[3.57],"unit":["3.57\u4e07"]},{"name":"\u5176\u4ed6","timeData":["2017-12-31","2017-06-30","2016-12-31"],"lineData":[3.96,3.8,2.7],"columnData":[3.96,3.8,2.7],"unit":["3.96\u4e07","3.80\u4e07","2.70\u4e07"]},{"name":"\u836f\u54c1","timeData":["2017-06-30","2016-12-31"],"lineData":[28.49,44.46],"columnData":[28.49,44.46],"unit":["28.49\u4e07","44.46\u4e07"]}],"chartWrap3":[{"name":"\u56fd\u5916","timeData":["2017-12-31"],"lineData":[68.61],"columnData":[68.61],"unit":["68.61\u4e07"]},{"name":"\u56fd\u5185","timeData":["2017-12-31"],"lineData":[31.39],"columnData":[31.39],"unit":["31.39\u4e07"]},{"name":"\u6d77\u5916\u5730\u533a","timeData":["2017-06-30"],"lineData":[67.71],"columnData":[67.71],"unit":["67.71\u4e07"]},{"name":"\u4e2d\u56fd\u5927\u9646","timeData":["2017-06-30","2016-12-31"],"lineData":[32.29,51.55],"columnData":[32.29,51.55],"unit":["32.29\u4e07","51.55\u4e07"]},{"name":"\u6d77\u5916","timeData":["2016-12-31"],"lineData":[48.45],"columnData":[48.45],"unit":["48.45\u4e07"]}]}}

营业收入 X

单位(%) 单位(万元)
注:通常在中报、年报时披露 
业务名称 营业收入(元) 收入比例 营业成本(元) 成本比例 利润比例 毛利率
按行业 医疗器械业 4.94亿 58.09% - - - -
药品及生物制品业 3.56亿 41.91% - - - -
按产品 设备及技术 4.94亿 58.09% 6068.11万 27.73% 68.61% 87.70%
自有药品 2.32亿 27.30% 8146.84万 37.23% 23.86% 64.88%
流通药品 7560.80万 8.90% 5309.57万 24.27% 3.57% 29.77%
其他 4853.20万 5.71% 2355.83万 10.77% 3.96% 51.46%
按地区 国外 4.94亿 58.09% 6068.11万 27.73% 68.61% 87.70%
国内 3.56亿 41.91% 1.58亿 72.27% 31.39% 55.60%

董事会经营评述

  一、业务回顾和展望  报告期内驱动业务收入变化的具体因素报告期内,公司归属于上市公司股东的净利润同比增长19.24%,导致业绩同比上升的主要原因有:一是公司主导药品复方鳖甲软肝片的销售有所回升;二是本期费用同比下降。  报告期内,公司实现营业收入174,973,279.78元,比上年同期增13.28%。实现归属于上市公司股东的净利润10,116,444.70元,比上年同期增长19.24%。实现归属于上市公司股东的扣除非经常性损益的净利润10,048,083.41元,比上年同期增长14.68%  二、重大风险提示  公司面临的风险及应对措施:  1、主营业务单一的风险公司目前的收入结构中,主... 查看全部▼

  一、业务回顾和展望
  报告期内驱动业务收入变化的具体因素报告期内,公司归属于上市公司股东的净利润同比增长19.24%,导致业绩同比上升的主要原因有:一是公司主导药品复方鳖甲软肝片的销售有所回升;二是本期费用同比下降。
  报告期内,公司实现营业收入174,973,279.78元,比上年同期增13.28%。实现归属于上市公司股东的净利润10,116,444.70元,比上年同期增长19.24%。实现归属于上市公司股东的扣除非经常性损益的净利润10,048,083.41元,比上年同期增长14.68%

  二、重大风险提示
  公司面临的风险及应对措施:
  1、主营业务单一的风险公司目前的收入结构中,主营业务仍主要集中在肝纤维化诊疗药品和肝脏诊断设备,其他业务在报告期内贡献相对较低。
  应对措施:公司将通过持续的并购努力拓展业务范围,在医疗器械、治疗药品和医疗服务三方面努力拓展,逐步实现各资源板块目标,使各业务模块均衡发展,提升公司盈利能力和抗风险能力。
  2、行业竞争及行业政策的风险
  随着全民健康意识的提高和医疗保障体制的进一步健全,肝病诊断、治疗未来的市场潜力巨大,会有更多的企业进入肝病诊疗市场,现有的企业也会加大市场投入和产品的研发。
  行业的整体竞争将更加剧烈,对公司产品销售和新产品研发都将产生压力。随着医药卫生体制改革的推进,医药分开、医生多点执业、分级诊疗等政策的进一步出台和落实,将带来医疗行业的新的机遇与竞争,将对公司持续提升市场竞争力与适应行业政策提出新的挑战。
  应对措施:面对行业竞争日益加剧,公司将加快战略转型的步伐,积极推进业务结构调整,加速非肝病领域的器械、药品和医疗服务的业务布局,增加持续盈利的业务种类。
  3、主要原材料价格波动带来产品毛利率波动的风险
  公司主要业务药品的原材料包括天然冬虫夏草、鳖甲、三七等,其中,冬虫夏草是公司主导药品复方鳖甲软肝片的最主要原材料。冬虫夏草的采购价格与上年同期相比有所上升,软肝片毛利率相比去年有所下降。未来冬虫夏草的价格仍存在波动风险,从而导致产品毛利率波动的风险。
  应对措施:为减小冬虫夏草价格波动的影响,公司主要采取三方面措施,第一,公司指派专人深入一线产地,利用虫草产新的有利时机直接收购,争取降低直接采购成本。第二,公司采取预付收购款的方式,提前锁定收购价格。第三,进一步加强采购价格制度和流程管理。此外,公司还将大力拓展业务范围,丰富公司产品品种和业务结构,从根本上缓解冬虫夏草价格波动对公司经营业绩的影响。
  4、肝病诊断产品和技术的开发风险
  公司目前的研发重点在肝纤维化诊断领域,公司将持续开发基于物理、血液、生化和基因检测的系列诊断产品,此外,还将持续整合各种肝病检测手段,应用医学信息技术工具,开发肝病诊断评估系统,为医生和患者提供一体化的肝病诊断和患者管理工具。因此,未来的研发过程中容易受到不可预测因素的影响,存在一定的技术开发风险。
  应对措施:针对技术开发风险,公司将研发工作的重心向法国倾斜,子公司法国Echosens拥有一支技术领先的肝病诊断技术研发团队,会紧密的结合肝病诊断方法的发展趋势,保持肝病评估领域的领先优势。此外,法国Echosens还将通过国际并购与合作,获得更多更有效的诊断技术产品,这些肝病诊断技术都将成为公司诊断系列产品的重要组成部分。 收起▲